|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-9-19
|
|
pubmed:abstractText |
Idarubicin is an effective drug in acute leukemia but its use in non-Hodgkin lymphomas (NHLs) is not yet well established. We evaluated its efficacy in patients with diffuse large cell lymphoma (DLCL) by means of a randomized trial comparing two 12-week regimens (VACOP-B and VICOP-B) which differed only in the anthracycline drug used (doxorubicin vs idarubicin).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
pubmed-author:BertiniMM,
pubmed-author:BottoBB,
pubmed-author:CalviRR,
pubmed-author:FreiloneRR,
pubmed-author:GallaminiAA,
pubmed-author:GattiA MAM,
pubmed-author:LiberatiA MAM,
pubmed-author:MeneghiniVV,
pubmed-author:OrlandiEE,
pubmed-author:OrsucciLL,
pubmed-author:PizzutiMM,
pubmed-author:ResegottiLL,
pubmed-author:Rota ScalabriniDD,
pubmed-author:SalviFF,
pubmed-author:TodeschiniGG,
pubmed-author:VitoloUU
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
309-13
|
|
pubmed:dateRevised |
2011-7-28
|
|
pubmed:meshHeading |
pubmed-meshheading:9234577-Adolescent,
pubmed-meshheading:9234577-Adult,
pubmed-meshheading:9234577-Aged,
pubmed-meshheading:9234577-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9234577-Bleomycin,
pubmed-meshheading:9234577-Cardiomyopathies,
pubmed-meshheading:9234577-Cyclophosphamide,
pubmed-meshheading:9234577-Doxorubicin,
pubmed-meshheading:9234577-Drug-Induced Liver Injury,
pubmed-meshheading:9234577-Etoposide,
pubmed-meshheading:9234577-Female,
pubmed-meshheading:9234577-Gastrointestinal Diseases,
pubmed-meshheading:9234577-Humans,
pubmed-meshheading:9234577-Idarubicin,
pubmed-meshheading:9234577-Infection,
pubmed-meshheading:9234577-Life Tables,
pubmed-meshheading:9234577-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:9234577-Male,
pubmed-meshheading:9234577-Middle Aged,
pubmed-meshheading:9234577-Neutropenia,
pubmed-meshheading:9234577-Prednisone,
pubmed-meshheading:9234577-Remission Induction,
pubmed-meshheading:9234577-Survival Analysis,
pubmed-meshheading:9234577-Treatment Outcome,
pubmed-meshheading:9234577-Vincristine
|
|
pubmed:articleTitle |
Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin).
|
|
pubmed:affiliation |
Divisione di Ematologia, Azienda Ospedaliera S. Giovanni Battista, Torino, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
